These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The value of urine sediment cytomorphology in the ambulatory differential diagnosis of hematuria]. Obroniecka I; Rojewska J; Wańkowicz Z Pol Merkur Lekarski; 1998 Nov; 5(29):285-7. PubMed ID: 10101502 [TBL] [Abstract][Full Text] [Related]
6. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364 [TBL] [Abstract][Full Text] [Related]
7. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813 [TBL] [Abstract][Full Text] [Related]
8. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer. Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; De Buitrago JM; Navajo JA J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897 [TBL] [Abstract][Full Text] [Related]
9. The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report. reichborn-Kjennerud S; Hoeg K Acta Cytol; 1972; 16(3):269-72. PubMed ID: 4503072 [No Abstract] [Full Text] [Related]
10. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer. Moonen PM; Kiemeney LA; Witjes JA Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108 [TBL] [Abstract][Full Text] [Related]
13. Diagnostics: A flow of information. Wald C Nature; 2017 Nov; 551(7679):S48-S50. PubMed ID: 29117161 [No Abstract] [Full Text] [Related]
14. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. Parekattil SJ; Fisher HA; Kogan BA J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812 [TBL] [Abstract][Full Text] [Related]
15. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer. Zippe C; Pandrangi L; Potts JM; Kursh E; Novick A; Agarwal A Anticancer Res; 1999; 19(4A):2621-3. PubMed ID: 10470205 [TBL] [Abstract][Full Text] [Related]
16. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors]. Gregersen B; Mommsen S; Svanholm H Ugeskr Laeger; 1999 Apr; 161(14):2071-3. PubMed ID: 10354792 [TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of bladder carcinoma]. Lent V Dtsch Med Wochenschr; 1975 Apr; 100(16):902-3. PubMed ID: 1122850 [No Abstract] [Full Text] [Related]
18. [Role of urinary cytology in the diagnosis and followup of bladder tumors. Review of 200 cases]. el Mezni F; Chebil M; Belhassine S; Zermani R; Jemni M; Ennigrou S; Ayed M; Ben Jilani S Tunis Med; 1998 Dec; 76(12):475-80. PubMed ID: 10093489 [No Abstract] [Full Text] [Related]
19. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy. Hedelin H; Jonsson K; Salomonsson K; Boman H Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma. Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]